Fulcrum Equity Management Johnson & Johnson Transaction History

Fulcrum Equity Management

$115 Million
Q3 2024

A detailed history of Fulcrum Equity Management transactions in Johnson & Johnson stock. As of the latest transaction made, Fulcrum Equity Management holds 3,927 shares of JNJ stock, worth $572,752. This represents 0.56% of its overall portfolio holdings.

Number of Shares

3,927

Previous 4,592 14.48%

Holding current value

$572,752

Previous $671,000 5.22%

% of portfolio

0.56%

Previous 0.62%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 21, 2024	SELL	$145.48 - $167.38 $96,744 - $111,307	-665 Reduced 14.48%	3,927 $636,000
Q2 2024 Jul 19, 2024	SELL	$144.38 - $157.78 $71,179 - $77,785	-493 Reduced 9.7%	4,592 $671,000
Q1 2024 Apr 24, 2024	BUY	$155.22 - $162.74 $56,810 - $59,562	366 Added 7.76%	5,085 $804,000
Q4 2023 Jan 18, 2024	SELL	$145.6 - $158.88 $84,884 - $92,627	-583 Reduced 11.0%	4,719 $739,000
Q3 2023 Nov 13, 2023	BUY	$155.75 - $174.48 $160,266 - $179,539	1,029 Added 24.08%	5,302 $825,000
Q2 2023 Jul 07, 2023	BUY	$154.35 - $166.11 $3,704 - $3,986	24 Added 0.56%	4,273 $707,000
Q1 2023 Apr 06, 2023	BUY	$151.05 - $180.26 $3,323 - $3,965	22 Added 0.52%	4,249 $658,000
Q4 2022 Jul 07, 2023	SELL	$160.2 - $179.79 $7,369 - $8,270	-46 Reduced 1.08%	4,227 $746,000
Q4 2022 Jan 10, 2023	BUY	$160.2 - $179.79 $4,485 - $5,034	28 Added 0.67%	4,227 $0
Q3 2022 Oct 11, 2022	BUY	$161.33 - $179.52 $4,194 - $4,667	26 Added 0.62%	4,199 $686,000
Q2 2022 Jul 18, 2022	BUY	$168.19 - $186.01 $10,595 - $11,718	63 Added 1.53%	4,173 $741,000
Q1 2022 Apr 15, 2022	BUY	$158.14 - $179.59 $5,851 - $6,644	37 Added 0.91%	4,110 $728,000
Q4 2021 Jan 25, 2022	BUY	$155.93 - $173.01 $4,210 - $4,671	27 Added 0.67%	4,073 $697,000
Q3 2021 Jan 25, 2022	BUY	$161.5 - $179.47 $59,593 - $66,224	369 Added 10.04%	4,046 $653,000
Q2 2021 Jul 15, 2021	BUY	$159.48 - $171.07 $3,827 - $4,105	24 Added 0.66%	3,677 $606,000
Q1 2021 Apr 05, 2021	BUY	$153.07 - $170.48 $3,520 - $3,921	23 Added 0.63%	3,653 $600,000
Q4 2020 Feb 22, 2021	BUY	$137.11 - $157.38 $3,290 - $3,777	24 Added 0.67%	3,630 $571,000
Q3 2020 Oct 27, 2020	SELL	$140.38 - $153.83 $7,159 - $7,845	-51 Reduced 1.39%	3,606 $537,000
Q2 2020 Aug 17, 2020	BUY	$128.81 - $155.51 $19,192 - $23,170	149 Added 4.25%	3,657 $514,000
Q1 2020 Apr 01, 2020	BUY	$111.14 - $153.99 $2,778 - $3,849	25 Added 0.72%	3,508 $460,000
Q4 2019 Feb 12, 2020	SELL	$127.5 - $146.44 $174,420 - $200,329	-1,368 Reduced 28.2%	3,483 $508,000
Q3 2019 Nov 05, 2019	BUY	$126.95 - $142.14 $4,443 - $4,974	35 Added 0.73%	4,851 $628,000
Q2 2019 Aug 12, 2019	SELL	$131.15 - $144.24 $297,841 - $327,569	-2,271 Reduced 32.04%	4,816 $636,000
Q1 2019 May 03, 2019	BUY	$125.72 - $139.79 $4,274 - $4,752	34 Added 0.48%	7,087 $991,000
Q4 2018 Mar 05, 2019	BUY	$122.84 - $147.84 $866,390 - $1.04 Million	7,053 New	7,053 $910,000

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulcrum Equity Management, based on Form 13F filings with the SEC.

News

Stay updated on Fulcrum Equity Management with notifications on news.

Account

Fulcrum Equity Management Johnson & Johnson Transaction History